Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Spark to charge 850,000 dollars per patient for blindness gene therapy

      Spark to charge 850,000 dollars per patient for blindness gene therapy

      Ruby Khatun Khatun4 Jan 2018 10:30 AM IST
      Spark Therapeutics Inc said it will charge $850,000 per patient for its breakthrough gene therapy to treat a rare form of blindness, a lower than the...
      FDA warning letter to German drugmaker for Baddi plant

      FDA warning letter to German drugmaker for Baddi plant

      Ruby Khatun Khatun4 Jan 2018 10:22 AM IST
      New Delhi: US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing facility...
      Novartis breast cancer therapy gets FDA breakthrough designation

      Novartis breast cancer therapy gets FDA breakthrough designation

      Ruby Khatun Khatun4 Jan 2018 10:00 AM IST
      ZURICH: Novartis’s Kisqali (ribociclib) has won U.S. Food and Drug Administration breakthrough therapy designation for treating some breast cancer...
      Momenta, Mylan plan trial of biosimilar to Regeneron eye drug

      Momenta, Mylan plan trial of biosimilar to Regeneron eye drug

      Ruby Khatun Khatun4 Jan 2018 9:30 AM IST
      Momenta Pharmaceuticals Inc and Mylan NV plan to begin a pivotal clinical trial of a biosimilar to Regeneron Pharmaceuticals Inc’s blockbuster eye...
      PMBJPs generic drugs upto 96 percent cheaper than branded equivalents

      PMBJPs generic drugs upto 96 percent cheaper than branded equivalents

      Ruby Khatun Khatun3 Jan 2018 12:30 PM IST
      New Delhi: The government is selling generic medicines at prices cheaper by up to 96 percent compared to their branded generic equivalents through its...
      Elite Pharmaceuticals gets FDA approval for Phendimetrazine Tartrate tablets

      Elite Pharmaceuticals gets FDA approval for Phendimetrazine Tartrate tablets

      Ruby Khatun Khatun3 Jan 2018 10:05 AM IST
      NORTHVALE: Elite Pharmaceuticals announced that it has received approval of the Company’s abbreviated new drug application (ANDA) from the U.S. Food...
      Johnson and Johnson heart device recalled: USFDA

      Johnson and Johnson heart device recalled: USFDA

      Ruby Khatun Khatun3 Jan 2018 10:00 AM IST
      The U.S. Food and Drug Administration on Tuesday issued a recall of a heart device made by a unit of Johnson & Johnson due to a faulty valve.The...
      New drug approvals in 2017 hits 21 year high

      New drug approvals in 2017 hits 21 year high

      Ruby Khatun Khatun3 Jan 2018 9:45 AM IST
      LONDON: U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light more than double the previous year while the...
      Drugmakers raise prices in US within self-imposed limits

      Drugmakers raise prices in US within self-imposed limits

      Ruby Khatun Khatun3 Jan 2018 9:30 AM IST
      NEW YORK: Drugmakers opened the new year by raising U.S. prices on dozens of medicines, but early data showed the increases generally remained within...
      NPPA fixes retail prices of 14 formulations

      NPPA fixes retail prices of 14 formulations

      Ruby Khatun Khatun2 Jan 2018 3:45 PM IST
      New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and...
      Indraprastha Medical Corp appoints Ashok Bajpai as MD

      Indraprastha Medical Corp appoints Ashok Bajpai as MD

      Ruby Khatun Khatun2 Jan 2018 11:00 AM IST
      New Delhi: Indraprastha Medical Corporation said Ashok Bajpai has been appointed as the Managing Director of the company for five years effective from...
      OrbiMed Asia makes 7.5 million dollars funding in Vivimed Labs

      OrbiMed Asia makes 7.5 million dollars funding in Vivimed Labs

      Ruby Khatun Khatun2 Jan 2018 10:30 AM IST
      New Delhi: Drug firm Vivimed Labs said it has received an additional investment of USD 7.5 million (over Rs 47 crore) from healthcare investment firm...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok